Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Publication Type:

Journal Article


The lancet oncology, Volume 15, Issue 8, p.841-51 (2014)


2014, Center-Authored Paper, Clinical Research Division, July 2014, Public Health Sciences Division


Treatment of patients with paediatric acute lymphoblastic leukaemia has evolved such that the risk of late effects in survivors treated in accordance with contemporary protocols could be different from that noted in those treated decades ago. We aimed to estimate the risk of late effects in children with standard-risk acute lymphoblastic leukaemia treated with contemporary protocols.